share_log

Needham Reiterates Buy on Pacira BioSciences, Maintains $45 Price Target

Moomoo 24/7 ·  Apr 9 06:16

Needham analyst Serge Belanger reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $45 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment